List of Tables
Table 1. HIV Therapy Drug CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. HIV Therapy Drug Market Trends
Table 3. HIV Therapy Drug Market Drivers
Table 4. HIV Therapy Drug Market Challenges
Table 5. HIV Therapy Drug Market Restraints
Table 6. Global HIV Therapy Drug Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States HIV Therapy Drug Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global HIV Therapy Drug Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States HIV Therapy Drug Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top HIV Therapy Drug Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global HIV Therapy Drug Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global HIV Therapy Drug Revenue Share by Manufacturer, 2017-2022
Table 13. Global HIV Therapy Drug Sales by Manufacturer, (K Units), 2017-2022
Table 14. Global HIV Therapy Drug Sales Share by Manufacturer, 2017-2022
Table 15. Global HIV Therapy Drug Price by Manufacturer (2017-2022) & (US$/Unit)
Table 16. Global HIV Therapy Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global HIV Therapy Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HIV Therapy Drug as of 2021)
Table 18. Top Players of HIV Therapy Drug in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers HIV Therapy Drug Product Type
Table 20. Date of International Manufacturers Enter into HIV Therapy Drug Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top HIV Therapy Drug Players in United States Market, Ranking by Revenue (2021)
Table 23. United States HIV Therapy Drug Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States HIV Therapy Drug Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States HIV Therapy Drug Sales by Players, (K Units), 2020, 2021 & 2022
Table 26. United States HIV Therapy Drug Sales Share by Players, 2020, 2021 & 2022
Table 27. Global HIV Therapy Drug Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global HIV Therapy Drug Sales in Volume by Region (2017-2022) & (K Units)
Table 29. Global HIV Therapy Drug Sales in Volume Forecast by Region (2023-2028) & (K Units)
Table 30. Global HIV Therapy Drug Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global HIV Therapy Drug Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America HIV Therapy Drug Sales in Volume by Country (2017-2028) & (K Units)
Table 33. North America HIV Therapy Drug Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific HIV Therapy Drug Sales in Volume by Region (2017-2028) & (K Units)
Table 35. Asia Pacific HIV Therapy Drug Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe HIV Therapy Drug Sales in Volume by Country (2017-2028) & (K Units)
Table 37. Europe HIV Therapy Drug Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America HIV Therapy Drug Sales in Volume by Country (2017-2028) & (K Units)
Table 39. Latin Americaa HIV Therapy Drug Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa HIV Therapy Drug Sales in Volume by Country (2017-2028) & (K Units)
Table 41. Middle East and Africa HIV Therapy Drug Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. ViiV Healthcare Corporation Information
Table 43. ViiV Healthcare Description and Business Overview
Table 44. ViiV Healthcare HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 45. ViiV Healthcare HIV Therapy Drug Product
Table 46. ViiV Healthcare Recent Development
Table 47. Gilead Sciences, Inc Corporation Information
Table 48. Gilead Sciences, Inc Description and Business Overview
Table 49. Gilead Sciences, Inc HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 50. Gilead Sciences, Inc Product
Table 51. Gilead Sciences, Inc Recent Development
Table 52. AbbVie Inc. Corporation Information
Table 53. AbbVie Inc. Description and Business Overview
Table 54. AbbVie Inc. HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 55. AbbVie Inc. Product
Table 56. AbbVie Inc. Recent Development
Table 57. Merck & Co Corporation Information
Table 58. Merck & Co Description and Business Overview
Table 59. Merck & Co HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 60. Merck & Co Product
Table 61. Merck & Co Recent Development
Table 62. GSK Corporation Information
Table 63. GSK Description and Business Overview
Table 64. GSK HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 65. GSK Product
Table 66. GSK Recent Development
Table 67. Bristol-Myers Squibb Company Corporation Information
Table 68. Bristol-Myers Squibb Company Description and Business Overview
Table 69. Bristol-Myers Squibb Company HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 70. Bristol-Myers Squibb Company Product
Table 71. Bristol-Myers Squibb Company Recent Development
Table 72. Theratechnologies Inc. Corporation Information
Table 73. Theratechnologies Inc. Description and Business Overview
Table 74. Theratechnologies Inc. HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 75. Theratechnologies Inc. Product
Table 76. Theratechnologies Inc. Recent Development
Table 77. Roche Holding AG Corporation Information
Table 78. Roche Holding AG Description and Business Overview
Table 79. Roche Holding AG HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 80. Roche Holding AG Product
Table 81. Roche Holding AG Recent Development
Table 82. Teva Pharmaceuticals Corporation Information
Table 83. Teva Pharmaceuticals Description and Business Overview
Table 84. Teva Pharmaceuticals HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 85. Teva Pharmaceuticals Product
Table 86. Teva Pharmaceuticals Recent Development
Table 87. Pfizer Corporation Information
Table 88. Pfizer Description and Business Overview
Table 89. Pfizer HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 90. Pfizer Product
Table 91. Pfizer Recent Development
Table 92. Frontier Biotechnologies Corporation Information
Table 93. Frontier Biotechnologies Description and Business Overview
Table 94. Frontier Biotechnologies HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 95. Frontier Biotechnologies Product
Table 96. Frontier Biotechnologies Recent Development
Table 97. Shionogi Corporation Information
Table 98. Shionogi Description and Business Overview
Table 99. Shionogi HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 100. Shionogi Product
Table 101. Shionogi Recent Development
Table 102. Janssen Pharmaceuticals, Inc. Corporation Information
Table 103. Janssen Pharmaceuticals, Inc. Description and Business Overview
Table 104. Janssen Pharmaceuticals, Inc. HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 105. Janssen Pharmaceuticals, Inc. Product
Table 106. Janssen Pharmaceuticals, Inc. Recent Development
Table 107. Mylan Pharmaceuticals Inc. Corporation Information
Table 108. Mylan Pharmaceuticals Inc. Description and Business Overview
Table 109. Mylan Pharmaceuticals Inc. HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 110. Mylan Pharmaceuticals Inc. Product
Table 111. Mylan Pharmaceuticals Inc. Recent Development
Table 112. Genentech, Inc. Corporation Information
Table 113. Genentech, Inc. Description and Business Overview
Table 114. Genentech, Inc. HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 115. Genentech, Inc. Product
Table 116. Genentech, Inc. Recent Development
Table 117. Boehringer Ingelheim Corporation Information
Table 118. Boehringer Ingelheim Description and Business Overview
Table 119. Boehringer Ingelheim HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 120. Boehringer Ingelheim Product
Table 121. Boehringer Ingelheim Recent Development
Table 122. Cipla Corporation Information
Table 123. Cipla Description and Business Overview
Table 124. Cipla HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 125. Cipla Product
Table 126. Cipla Recent Development
Table 127. MSD Corporation Information
Table 128. MSD Description and Business Overview
Table 129. MSD HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 130. MSD Product
Table 131. MSD Recent Development
Table 132. Abbott Corporation Information
Table 133. Abbott Description and Business Overview
Table 134. Abbott HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 135. Abbott Product
Table 136. Abbott Recent Development
Table 137. Johnson & Johnson Corporation Information
Table 138. Johnson & Johnson Description and Business Overview
Table 139. Johnson & Johnson HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 140. Johnson & Johnson Product
Table 141. Johnson & Johnson Recent Development
Table 142. Biocon Limited Corporation Information
Table 143. Biocon Limited Description and Business Overview
Table 144. Biocon Limited HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 145. Biocon Limited Product
Table 146. Biocon Limited Recent Development
Table 147. Affine Formulations Limited Corporation Information
Table 148. Affine Formulations Limited Description and Business Overview
Table 149. Affine Formulations Limited HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 150. Affine Formulations Limited Product
Table 151. Affine Formulations Limited Recent Development
Table 152. IPCA Laboratories Corporation Information
Table 153. IPCA Laboratories Description and Business Overview
Table 154. IPCA Laboratories HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 155. IPCA Laboratories Product
Table 156. IPCA Laboratories Recent Development
Table 157. Natco Pharma Corporation Information
Table 158. Natco Pharma Description and Business Overview
Table 159. Natco Pharma HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 160. Natco Pharma Product
Table 161. Natco Pharma Recent Development
Table 162. Beacon Pharmaceuticals Corporation Information
Table 163. Beacon Pharmaceuticals Description and Business Overview
Table 164. Beacon Pharmaceuticals HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 165. Beacon Pharmaceuticals Product
Table 166. Beacon Pharmaceuticals Recent Development
Table 167. Julphar Bangladesh Corporation Information
Table 168. Julphar Bangladesh Description and Business Overview
Table 169. Julphar Bangladesh HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 170. Julphar Bangladesh Product
Table 171. Julphar Bangladesh Recent Development
Table 172. Key Raw Materials Lists
Table 173. Raw Materials Key Suppliers Lists
Table 174. HIV Therapy Drug Customers List
Table 175. HIV Therapy Drug Distributors List
Table 176. Research Programs/Design for This Report
Table 177. Key Data Information from Secondary Sources
Table 178. Key Data Information from Primary Sources
List of Figures
Figure 1. HIV Therapy Drug Product Picture
Figure 2. Global HIV Therapy Drug Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global HIV Therapy Drug Market Size 2017-2028 (US$ Million)
Figure 4. Global HIV Therapy Drug Sales 2017-2028 (K Units)
Figure 5. United States HIV Therapy Drug Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States HIV Therapy Drug Market Size 2017-2028 (US$ Million)
Figure 7. United States HIV Therapy Drug Sales 2017-2028 (K Units)
Figure 8. United States HIV Therapy Drug Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States HIV Therapy Drug Market Share in Global, in Volume (K Units) 2017-2028
Figure 10. HIV Therapy Drug Report Years Considered
Figure 11. Product Picture of Multi-Type Combined Drugs
Figure 12. Product Picture of Nucleoside Reverse Transcription Enzyme Inhibitors
Figure 13. Product Picture of Non-Nucleoside Reverse Transcription Enzyme Inhibitors
Figure 14. Product Picture of Hiv Integrated Enzyme Chain Transfer Inhibitor
Figure 15. Global HIV Therapy Drug Market Share by Type in 2022 & 2028
Figure 16. Global HIV Therapy Drug Sales in Value by Type (2017-2028) & (US$ Million)
Figure 17. Global HIV Therapy Drug Sales Market Share in Value by Type (2017-2028)
Figure 18. Global HIV Therapy Drug Sales by Type (2017-2028) & (K Units)
Figure 19. Global HIV Therapy Drug Sales Market Share in Volume by Type (2017-2028)
Figure 20. Global HIV Therapy Drug Price by Type (2017-2028) & (US$/Unit)
Figure 21. United States HIV Therapy Drug Market Share by Type in 2022 & 2028
Figure 22. United States HIV Therapy Drug Sales in Value by Type (2017-2028) & (US$ Million)
Figure 23. United States HIV Therapy Drug Sales Market Share in Value by Type (2017-2028)
Figure 24. United States HIV Therapy Drug Sales by Type (2017-2028) & (K Units)
Figure 25. United States HIV Therapy Drug Sales Market Share in Volume by Type (2017-2028)
Figure 26. United States HIV Therapy Drug Price by Type (2017-2028) & (US$/Unit)
Figure 27. Product Picture of Hospital
Figure 28. Product Picture of Clinic
Figure 29. Product Picture of Pharmacy
Figure 30. Global HIV Therapy Drug Market Share by Application in 2022 & 2028
Figure 31. Global HIV Therapy Drug Sales in Value by Application (2017-2028) & (US$ Million)
Figure 32. Global HIV Therapy Drug Sales Market Share in Value by Application (2017-2028)
Figure 33. Global HIV Therapy Drug Sales by Application (2017-2028) & (K Units)
Figure 34. Global HIV Therapy Drug Sales Market Share in Volume by Application (2017-2028)
Figure 35. Global HIV Therapy Drug Price by Application (2017-2028) & (US$/Unit)
Figure 36. United States HIV Therapy Drug Market Share by Application in 2022 & 2028
Figure 37. United States HIV Therapy Drug Sales in Value by Application (2017-2028) & (US$ Million)
Figure 38. United States HIV Therapy Drug Sales Market Share in Value by Application (2017-2028)
Figure 39. United States HIV Therapy Drug Sales by Application (2017-2028) & (K Units)
Figure 40. United States HIV Therapy Drug Sales Market Share in Volume by Application (2017-2028)
Figure 41. United States HIV Therapy Drug Price by Application (2017-2028) & (US$/Unit)
Figure 42. North America HIV Therapy Drug Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 43. North America HIV Therapy Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 44. United States HIV Therapy Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 45. Canada HIV Therapy Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 46. Europe HIV Therapy Drug Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 47. Europe HIV Therapy Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 48. Germany HIV Therapy Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. France HIV Therapy Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. U.K. HIV Therapy Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. Italy HIV Therapy Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 52. Russia HIV Therapy Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 53. Asia-Pacific HIV Therapy Drug Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 54. Asia-Pacific HIV Therapy Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 55. China HIV Therapy Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. Japan HIV Therapy Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. South Korea HIV Therapy Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. India HIV Therapy Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Australia HIV Therapy Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. China Taiwan HIV Therapy Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Indonesia HIV Therapy Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Thailand HIV Therapy Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Malaysia HIV Therapy Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 64. Latin America HIV Therapy Drug Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 65. Latin America HIV Therapy Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 66. Mexico HIV Therapy Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Brazil HIV Therapy Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Argentina HIV Therapy Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 69. Colombia HIV Therapy Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 70. Middle East & Africa HIV Therapy Drug Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 71. Middle East & Africa HIV Therapy Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 72. Turkey HIV Therapy Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. Saudi Arabia HIV Therapy Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 74. UAE HIV Therapy Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 75. HIV Therapy Drug Value Chain
Figure 76. HIV Therapy Drug Production Process
Figure 77. Channels of Distribution
Figure 78. Distributors Profiles
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed